23 results
424B5
COGT
Cogent Biosciences Inc
2 Dec 20
Prospectus supplement for primary offering
5:06pm
. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the Paragraph IV certification. The filing … of a patent infringement lawsuit within 45 days after the receipt of a Paragraph IV certification automatically prevents the FDA from approving
424B5
ewo1 133orn
30 Nov 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.2
bqzrl
26 Oct 20
Cogent Biosciences Appoints
7:13am
DEFM14A
bci89v5
9 Oct 20
Proxy related to merger
4:44pm
8-K
EX-10.1
wqjh z93vzoah
10 Aug 20
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-2.1
qlzwjm
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
424B5
icxi53qy6j 82ap689wi
20 Mar 20
Prospectus supplement for primary offering
8:26am
10-K
1w4 hzli0
28 Mar 19
Annual report
7:31am